1. The Role of Pharmacogenetics in the Metabolism of Antiepileptic Drugs

   • Ulrich Klotz

   Leading Article 30 September 2012 Pages: 271 - 279

   

2. The Clinical Pharmacokinetics of Escitalopram

   • Niranjan Rao

   Review Article 30 September 2012 Pages: 281 - 290

   

3. Pharmacokinetic Characteristics of Antimicrobials and Optimal Treatment of Urosepsis

   • Florian M. E. Wagenlehner
   • Wolfgang Weidner
   • Kurt G. Naber

   Review Article 30 September 2012 Pages: 291 - 305

   

4. Effect of Time, Injury, Age and Ethanol on Interpatient Variability in Valproic Acid Pharmacokinetics after Traumatic Brain Injury

   • Gail D. Anderson
   • Nancy R. Temkin
   • H. Richard Winn

   Original Research Article 30 September 2012 Pages: 307 - 318

   

5. Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin’s Lymphoma and its Effect on Myelotoxicity

   • Stefan Wilde
   • Alexander Jetter
   • Uwe Fuhr

   Original Research Article 30 September 2012 Pages: 319 - 333

   

6. Safety, Pharmacokinetics and Pharmocodynamics of Recombinant Human Porphobilinogen Deaminase in Healthy Subjects and Asymptomatic Carriers of the Acute Intermittent Porphyria Gene Who Have Increased Porphyrin Precursor Excretion

   • Eliane Sardh
   • Lillan Rejkjær
   • Pauline Harper

   Original Research Article 30 September 2012 Pages: 335 - 349

   

7. Tolerability, Safety and Pharmacokinetics of the FGL_L Peptide, a Novel Mimetic of Neural Cell Adhesion Molecule, Following Intranasal Administration in Healthy Volunteers

   • Ravi Anand
   • Michael Seiberling
   • Rolf Pokorny

   Original Research Article 30 September 2012 Pages: 351 - 358